World's Best Scientists 2026 revealed!
Alessandro Moretta

Alessandro Moretta

Award Badge
Immunology
Italy
2023
Award Badge
Medicine
Italy
2023

D-Index & Metrics

Immunology

D-Index
152
Citations
77915
World Ranking
114
National Ranking
4

Medicine

D-Index
152
Citations
77937
World Ranking
1086
National Ranking
25

Alessandro Moretta publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Alessandro Moretta sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 506 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Alessandro Moretta D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Alessandro Moretta sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 152 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Immunology in Italy Leader Award
  • 2023 - Research.com Medicine in Italy Leader Award
  • 2022 - Research.com Immunology in Italy Leader Award

Overview

Alessandro Moretta was affiliated with the University of Genoa in Italy and contributed to the fields of Immunology and Microbiology as well as Medicine. Their research primarily revolved around Immunology, with additional focus on Hematology and Oncology subfields.

The scientist's main topics of work included:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Hematopoietic Stem Cell Transplantation
  • CAR-T cell therapy research

Moretta's recent publications covered various aspects of immune cell biology and therapeutic interventions. These included:

  • "Phenotypic and Functional Characterization of NK Cells in αβT-Cell and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients with Acute Leukemia" (2020) published in Cancers
  • "HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors" (2021) published in Journal of Allergy and Clinical Immunology
  • "291P: Preliminary results of cytisine therapy and tobacco cessation program in the Italian lung cancer screening program" (2025) published in Journal of Thoracic Oncology

Their work involved collaboration with several frequent coauthors, including Mariella Della Chiesa, Francesca Moretta, Letizia Muccio, Lorenzo Moretta, and Raffaella Meazza. These collaborations contributed to the breadth and depth of their investigative efforts in immune system functioning and therapeutic applications.

Moretta's research was disseminated through journals such as Cancers, Journal of Allergy and Clinical Immunology, and Journal of Thoracic Oncology, reflecting the interdisciplinary nature of their studies bridging basic immunology and clinical medicine.

Best Publications

  • Innate or Adaptive Immunity? The Example of Natural Killer Cells

    Eric Vivier;David H. Raulet;Alessandro Moretta;Michael A. Caligiuri

  • Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

    Alessandro Moretta;Cristina Bottino;Massimo Vitale;Daniela Pende

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

    Cristina Bottino;Roberta Castriconi;Daniela Pende;Paola Rivera

  • RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS

    Alessandro Moretta;Cristina Bottino;Massimo Vitale;Daniela Pende

  • Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

    Daniela Pende;Silvia Parolini;Anna Pessino;Simona Sivori

  • NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis

    Massimo Vitale;Cristina Bottino;Simona Sivori;Lorenza Sanseverino

  • Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

    Hideyuki Ikeda;Bernard Lethé;Frédéric Lehmann;Nicolas Van Baren

  • Natural killer cells and dendritic cells: rendezvous in abused tissues

    Alessandro Moretta

  • The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

    Cameron S. Brandt;Myriam Baratin;Myriam Baratin;Eugene C Yi;Jacob Kennedy

  • Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells

    Roberta Castriconi;Claudia Cantoni;Mariella Della Chiesa;Massimo Vitale

  • P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.

    Alessandro Moretta;Massimo Vitale;Cristina Bottino;Anna Maria Orengo

  • Unravelling natural killer cell function: triggering and inhibitory human NK receptors.

    Lorenzo Moretta;Lorenzo Moretta;Alessandro Moretta

  • Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

    Emilie Mamessier;Aude Sylvain;Marie-Laure Thibult;Gilles Houvenaeghel

  • Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.

    Anna Pessino;Simona Sivori;Cristina Bottino;Angela Malaspina

  • The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic

    Guido Ferlazzo;Dolca Thomas;Shao Lee Lin;Kiera Goodman

  • Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

    Nicolai Wagtmann;Roberto Biassoni;Claudia Cantoni;Simonetta Verdiani

  • X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells

    Silvia Parolini;Cristina Bottino;Michela Falco;Raffaella Augugliaro

  • p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation

    Simona Sivori;Massimo Vitale;Luigia Morelli;Lorenza Sanseverino

  • Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

    Domenico Mavilio;Gabriella Lombardo;Janet Benjamin;Diana Kim

Frequent Co-Authors

Lorenzo Moretta
Lorenzo Moretta Bambino Gesù Children's Hospital
Cristina Bottino
Cristina Bottino University of Genoa
Daniela Pende
Daniela Pende University of Genoa
Maria Cristina Mingari
Maria Cristina Mingari University of Genoa
Emanuela Marcenaro
Emanuela Marcenaro University of Genoa
Simona Sivori
Simona Sivori University of Genoa
Claudia Cantoni
Claudia Cantoni University of Genoa
Roberto Biassoni
Roberto Biassoni Istituto Giannina Gaslini
Michela Falco
Michela Falco Istituto Giannina Gaslini
Massimo Vitale
Massimo Vitale University of Genoa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise into healthcare roles like nurse practitioner specialties can enhance your career prospects. Many professionals pursue specialized training through programs recognized for their strong clinical training, such as the best online psychiatric mental health nurse practitioner programs. These programs often balance rigorous academics with hands-on experience, critical for success in clinical settings.

Cost is a significant factor when choosing an advanced degree, and affordable options are available. Students can explore the cheapest psych np programs online to find quality education without overextending their budget.

Career transitions are also common in healthcare. For example, nurses looking to deepen their practice might consider pathways such as fnp to acute care np, which offer new specialization opportunities and broadened clinical roles. Understanding these transitions helps immunology professionals align their career goals with industry needs.

Lastly, salary expectations vary widely by location and specialization. Reviewing data on dnp salary by state can provide valuable insight into earning potential and help guide your educational and professional trajectory.

Best Scientists Citing Alessandro Moretta

Recently Published Articles